Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Not yet recruiting

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

NCT07112612

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

NCT07301138

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW)

NCT07269067

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study

NCT07264010

Conditions: Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

NCT07257380

Conditions: Gastric / Gastroesophageal Junction Adenocarcinoma, Neoplasm, Residual, Neoplasms, +3 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Risk-adapted Therapeutic Strategy in +1q NDMM

NCT07045168

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not yet recruiting

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

NCT06941987

Conditions: Minimal Residual Disease, Neoplasm, Residual, Neoplasms, +4 more
Locations: Zhongshan Hospital, Shanghai Shanghai, China

View Trial Details

Not yet recruiting

A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

NCT06854939

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: National Cancer Center Hospital Chuo-ku, Tokyo, Japan

View Trial Details

Not yet recruiting

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

NCT06763302

Conditions: B Cell Precursor Acute Lymphoblastic Leukemia, Minimal Residual Disease, Neoplasm, Residual, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

NCT06449846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: Shunde Hospital of Southern Medical University Foshan, Guangdong, China

The Sixth Affiliated Hospital of South China University of Technology Foshan, Guangdong, China

Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Neoplasm, Residual

Neoplasm, Residual trial results

Related conditions